Importer of Controlled Substances, Notice of Registration, Myoderm, 5498 [2013-01540]
Download as PDF
<![CDATA[
5498
Federal Register / Vol. 78, No. 17 / Friday, January 25, 2013 / Notices
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Registration; R & D Systems,
Inc.
By Notice dated August 17, 2012, and
published in the Federal Register on
August 20, 2012, 77 FR 50162, R & D
Systems, Inc., 614 McKinley Place NE.,
Minneapolis, Minnesota 55413, made
application to the Drug Enforcement
Administration (DEA) to be registered as
an importer of the following basic
classes of controlled substances:
Drug
Schedule
mstockstill on DSK4VPTVN1PROD with
1-Pentyl-3-(1-naphthoyl)indole
(7118).
5-(1,1-Dimethylheptyl)-2-[(1R,3S)3- hydroxycyclohexyl]- phenol
(7297).
Marihuana (7360) .........................
Tetrahydrocannabinols (7370) .....
4-Bromo-2,5dimethoxyamphetamine (7391).
3,4Methylenedioxymethamphetamine (7405).
Dimethyltryptamine (7435) ...........
Amphetamine (1100) ....................
Methylphenidate (1724) ................
Phencyclidine (7471) ....................
Cocaine (9041) .............................
Oxycodone (9143) ........................
Thebaine (9333) ...........................
Fentanyl (9801) ............................
I
18:39 Jan 24, 2013
I
I
I
I
[FR Doc. 2013–01554 Filed 1–24–13; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances,
Notice of Registration, Myoderm
Drug
I
II
II
II
II
II
II
II
Jkt 229001
Dated: January 15, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
By Notice dated June 28, 2012, and
published in the Federal Register on
July 5, 2012, 77 FR 39741, Myoderm, 48
East Main Street, Norristown,
Pennsylvania 19401, made application
to the Drug Enforcement Administration
(DEA) to be registered as an importer of
the following basic classes of controlled
substances:
I
The company plans to import the
listed controlled substances in dosage
form to distribute to researchers.
In reference to drug codes 7360 and
7370, the company plans to import a
synthetic cannabidiol and a synthetic
Tetrahydrocannabinol. No other activity
for this drug code is authorized for this
registration.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a),
and determined that the registration of
R & D Systems, Inc., to import the basic
classes of controlled substances is
consistent with the public interest, and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971, at
this time. DEA has investigated R & D
Systems, Inc., to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
VerDate Mar<15>2010
with 21 CFR § 1301.34, the above named
company is granted registration as an
importer of the basic classes of
controlled substances listed.
Schedule
Amphetamine (1100) ....................
Lisdexamfetamine (1205) .............
Methylphenidate (1724) ................
Pentobarbital (2270) .....................
Nabilone (7379) ............................
Codeine (9050) .............................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Hydrocodone (9193) .....................
Levomethorphan (9210) ...............
Meperidine (9230) ........................
Methadone (9250) ........................
Methadone intermediate (9254) ...
Morphine (9300) ...........................
Oxymorphone (9652) ...................
Fentanyl (9801) ............................
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
The company plans to import the
listed controlled substances in finished
dosage form for clinical trials, and
research.
The import of the above listed basic
classes of controlled substances is
granted only for analytical testing and
clinical trials. This authorization does
not extend to the import of a finished
FDA approved or non-approved dosage
form for commercial distribution in the
United States.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a),
and determined that the registration of
Myoderm, to import the basic classes of
controlled substances is consistent with
the public interest, and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971, at this time. DEA
PO 00000
Frm 00092
Fmt 4703
Sfmt 4703
has investigated Myoderm, to ensure
that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic classes of controlled
substances listed.
Dated: January 15, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2013–01540 Filed 1–24–13; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Registration; Chattem
Chemicals, Inc.
By Notice dated June 28, 2012, and
published in the Federal Register on
July 6, 2012, 77 FR 40086, Chattem
Chemicals, Inc., 3801 St. Elmo Avenue,
Chattanooga, Tennessee 37409, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as an importer of the
following basic classes of controlled
substances:
Drug
Methamphetamine (1105) ............
4-Anilino-N-phenethyl-4-piperidine
(8333).
Phenylacetone (8501) ..................
Opium, raw (9600) .......................
Poppy Straw Concentrate (9670)
Tapentadol (9780) ........................
Schedule
II
II
II
II
II
II
The company plans to import the
listed controlled substances to
manufacture bulk controlled substances
for sale to its customers.
The company plans to import an
intermediate form of Tapentadol (9780),
to bulk manufacture Tapentadol for
distribution to its customers.
Comments and requests for hearing on
applications to import narcotic raw
material are not appropriate, 72 FR
3417(2007).
Regarding all other basic classes of
controlled substances, no comments or
objections have been received. DEA has
considered the factors in 21 U.S.C.
823(a) and 952(a), and determined that
E:\FR\FM\25JAN1.SGM
25JAN1
]]>Agencies
[Federal Register Volume 78, Number 17 (Friday, January 25, 2013)]
[Notices]
[Page 5498]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-01540]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances, Notice of Registration,
Myoderm
By Notice dated June 28, 2012, and published in the Federal
Register on July 5, 2012, 77 FR 39741, Myoderm, 48 East Main Street,
Norristown, Pennsylvania 19401, made application to the Drug
Enforcement Administration (DEA) to be registered as an importer of the
following basic classes of controlled substances:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Amphetamine (1100)......................... II
Lisdexamfetamine (1205).................... II
Methylphenidate (1724)..................... II
Pentobarbital (2270)....................... II
Nabilone (7379)............................ II
Codeine (9050)............................. II
Oxycodone (9143)........................... II
Hydromorphone (9150)....................... II
Hydrocodone (9193)......................... II
Levomethorphan (9210)...................... II
Meperidine (9230).......................... II
Methadone (9250)........................... II
Methadone intermediate (9254).............. II
Morphine (9300)............................ II
Oxymorphone (9652)......................... II
Fentanyl (9801)............................ II
------------------------------------------------------------------------
The company plans to import the listed controlled substances in
finished dosage form for clinical trials, and research.
The import of the above listed basic classes of controlled
substances is granted only for analytical testing and clinical trials.
This authorization does not extend to the import of a finished FDA
approved or non-approved dosage form for commercial distribution in the
United States.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and 952(a), and determined that the
registration of Myoderm, to import the basic classes of controlled
substances is consistent with the public interest, and with United
States obligations under international treaties, conventions, or
protocols in effect on May 1, 1971, at this time. DEA has investigated
Myoderm, to ensure that the company's registration is consistent with
the public interest. The investigation has included inspection and
testing of the company's physical security systems, verification of the
company's compliance with state and local laws, and a review of the
company's background and history. Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above
named company is granted registration as an importer of the basic
classes of controlled substances listed.
Dated: January 15, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2013-01540 Filed 1-24-13; 8:45 am]
BILLING CODE 4410-09-P
